Skip to main content

Organigram Holdings Inc (OGI-T) Quote

Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 3.35
Day High 4.18
Open:3.54
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
OrganiGram Holdings Inc is a Canada licensed producer of cannabis products. The company focuses on producing indoor-growth cannabis for patients and adult recreational consumers, as well as developing overseas business partnerships.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Spending on Cannabis Continues to Grow in Legalized Regions
- PR Newswire - Thu Nov 14, 8:00AM CST
PR Newswire - CMTX
Thu Nov 14, 8:00AM CST
Due to various recent regulatory changes, the cannabis industry is slowly evolving out of the black market and morphing into a global economic powerhouse. While cannabis still remains heavily regulated in most regions around the world, a handful of countries have moved to legalize cannabis for either medical or recreational use. Notably, only Canada and Uruguay have completely legalized cannabis yet it is the U.S. that accounts for the majority of the global market share. In fact, the U.S. is the largest individual market primarily because of its massive addressable market as well as its early adoption. To note, the U.S. has not federally legalized cannabis, but instead gave states the jurisdiction to decide for themselves. Consequently, 11 states and the District of Columbia moved to legalize recreational cannabis, while more than half the country approved medical cannabis use. In particular, California was the first state to adopt medical cannabis back in 1996. And shortly after, Oregon, Alaska, and Washington joined California and legalized medicinal cannabis in 1998. However, Colorado and Washington completely reshaped the entire industry after the two states moved to legalize recreational adult-use in 2014. By 2015, Colorado reported total cannabis sales of USD 995.59 Million, while Washington reported total sales of USD 486 Million. Meanwhile, Canada reportedly sold approximately USD 1.1 Billion worth of cannabis in the past 12 months, according to Cannabis Benchmark. Moreover, Canada recently launched its "Cannabis 2.0" program, which legalized additional cannabis products such as edibles and beverages. Now, the rapidly growing North American market is anticipated to push the global cannabis industry into mainstream markets. And according to data compiled by Ahead Intel, the global cannabis market was estimated at USD 14.5 Billion in 2018. By 2025, the market is expected to reach USD 107.67 Billion, exhibiting a CAGR of 33.17%. Pasha Brands Ltd. (OTC: CRFTF) (CSE: CRFT), HEXO Corp. (NYSE: HEXO) (TSX: HEXO), OrganiGram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), The Green Organic Dutchman Holdings Ltd. (OTC: TGODF) (TSX: TGOD), Emerald Health Therapeutics Inc. (OTC: EMHTF) (TSX-V: EMH).
Organigram Provides Corporate Update
- BusinessWire - Mon Nov 11, 5:30PM CST
BusinessWire - CMTX
Mon Nov 11, 5:30PM CST
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, provided a corporate update today and announced details for its fiscal fourth quarter ended August 31, 2019 ("Q4 2019") and full year 2019 conference call. The Company is scheduled to report its fourth quarter and full year earnings results for its fiscal year ended August 31, 2019 on Monday, November 25, 2019 before market open.
Organigram Wins Top Product Award in High THC Bottled Oil Category at 2019 Canadian Cannabis Awards
- BusinessWire - Mon Nov 11, 5:00AM CST
BusinessWire - CMTX
Mon Nov 11, 5:00AM CST
--Awards validate strategic focus on innovation, quality and commitment to customer experience
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 2.64 +48.86% increase
on 11/19/19
Period Open:4.67
Price movement based on the high, low and last over the given period.
5.23 -24.86% decrease
on 10/28/19
-0.74 (-15.85%) decrease
since 10/21/19
3-Month 2.64 +48.86% increase
on 11/19/19
Period Open:6.85
Price movement based on the high, low and last over the given period.
6.91 -43.13% decrease
on 08/22/19
-2.92 (-42.63%) decrease
since 08/21/19
52-Week 2.64 +48.86% increase
on 11/19/19
Period Open:5.40
Price movement based on the high, low and last over the given period.
11.30 -65.22% decrease
on 05/21/19
-1.47 (-27.22%) decrease
since 11/21/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).